Depression
Opinion
Canadian Task Force recommendation on screening for postpartum depression misses the mark
The task force recently recommended against screening with systematic questionnaires, noting that benefits were unclear and not a particular...
From the Journals
Anxiety sensitivity fuels depression in dissociative identity disorder
Patients’ fear of cognitive anxiety symptoms contributes to dissociation through depression.
From the Journals
Borderline patients have longer time to depression remission
Severity of BPD symptoms could be an indicator of more severe depression.
From the Journals
Low serum LDH shows potential as depression biomarker
Decreased LDH also was an independent risk factor for suicide in adults with major depressive disorder.
From the Journals
Self-management app may boost quality of life
The smartphone intervention was significantly associated with a reduction in depressive symptoms vs usual care.
From the Journals
Postconcussion symptoms tied to high risk of depression
Depressive symptoms, in turn, predict more prolonged postconcussion recovery.
From the Journals
Sleep complaints in major depression flag risk for other psychiatric disorders
Investigators studied 3-year incidence rates of psychiatric disorders in almost 3,000 patients experiencing a major depressive episode.
Commentary
Medical student well-being during the COVID-19 pandemic
Social isolation and uncertainty regarding future education opportunities appear to have had a detrimental effect on medical students’...
From the Journals
More evidence suicidal thoughts, behaviors are genetically based
“We need to take the next step, which is to try to understand how these genetic factors may impact risk,” said Dr. Allison E. Ashley-Koch.
From the Journals
Is the FDA serotonin syndrome warning unnecessary?
“This retrospective epidemiologic study ... has consequential relevance in clinical practice for the management of severe infections among older...
From the Journals
IV ketamine a promising option for resistant depression in older adults
Nearly 50% of participants responded to ketamine and 25% achieved complete remission from TRD.